We are live on ! Find out more
State Street

State Street Portfolio holdings

AUM $2.9T
1-Year Est. Return 29.55%
 

State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.

This Fund
S&P 500
This Quarter Est. Return
+8.55%
1 Year Est. Return
+29.55%
3 Year Est. Return
+97.16%
5 Year Est. Return
+133.33%
10 Year Est. Return
+488.13%
AUM
$1.9T
AUM Growth
+$132B
Cap. Flow
+$9.62B
Cap. Flow %
0.51%
Top 10 Hldgs %
23.28%
Holding
4,852
New
71
Increased
2,184
Reduced
1,624
Closed
173

Top Buys

Rank Stock Value
1
PANW icon
Palo Alto Networks
PANW
+$1.15B
2
TSLA icon
Tesla
TSLA
+$886M
3
MSFT icon
Microsoft
MSFT
+$472M
4
AAPL icon
Apple
AAPL
+$456M
5
AMZN icon
Amazon
AMZN
+$453M

Sector Composition

Rank Sector Weight
1 Technology 25.22%
2 Healthcare 13.75%
3 Financials 12.13%
4 Consumer Discretionary 9.96%
5 Industrials 9.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBX
4051
DELISTED
Unity Biotechnology
UBX
$96.5K ﹤0.01%
37,824
-340
-0.9% -$898
BMTX
4052
DELISTED
BM Technologies, Inc.
BMTX
$96.3K ﹤0.01%
32,323
TCRX icon
4053
TScan Therapeutics
TCRX
$48.1M
$96.3K ﹤0.01%
38,500
+14,500
+60% +$38.9K
ALGS icon
4054
Aligos Therapeutics
ALGS
$29.4M
$94.6K ﹤0.01%
3,897
APRN
4055
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$94.5K ﹤0.01%
16,177
+8,696
+116% +$58.8K
DAVE icon
4056
Dave Inc
DAVE
$5.46B
$93.9K ﹤0.01%
17,612
BINI
4057
DELISTED
Bollinger Innovations
BINI
0
LPCN icon
4058
Lipocine
LPCN
$17.6M
$93.1K ﹤0.01%
18,626
+1
+0% +$5
FLNT
4059
Fluent
FLNT
$104M
$93K ﹤0.01%
24,748
-293
-1% -$1.23K
VIRX
4060
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$92.9K ﹤0.01%
65,867
QUBT icon
4061
Quantum Computing Inc
QUBT
$2.08B
$91.8K ﹤0.01%
77,832
ADN
4062
DELISTED
Advent Technologies
ADN
$91.3K ﹤0.01%
5,173
-170
-3% -$4.11K
INAB icon
4063
IN8bio
INAB
$9.45M
$91.2K ﹤0.01%
+1,975
New +$123K
PETV
4064
DELISTED
PetVivo Holdings, Inc. Common Stock
PETV
$91.1K ﹤0.01%
46,229
GROY icon
4065
Gold Royalty Corp
GROY
$621M
$91.1K ﹤0.01%
51,444
-919
-2% -$1.9K
BRTX icon
4066
BioRestorative Therapies
BRTX
$5.35M
$90.2K ﹤0.01%
20,459
PPSI
4067
Pioneer Power Solutions
PPSI
$34.3M
$90.1K ﹤0.01%
10,728
BCEL
4068
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
$89.7K ﹤0.01%
91,520
CTHR
4069
DELISTED
Charles & Colvard Ltd
CTHR
$88.9K ﹤0.01%
9,305
NAII icon
4070
Natural Alternatives International
NAII
$14.6M
$88.8K ﹤0.01%
11,963
SFT
4071
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
$88.7K ﹤0.01%
40,871
EMKR
4072
DELISTED
Emcore Corp
EMKR
$88.5K ﹤0.01%
11,762
-233
-2% -$2.11K
SYRE icon
4073
Spyre Therapeutics
SYRE
$9.11B
$87.9K ﹤0.01%
7,804
-796
-9% -$3.77K
CYPH
4074
Cypherpunk Technologies Inc
CYPH
$73.5M
$86.7K ﹤0.01%
27,713
+9,939
+56% +$49.9K
BTCY
4075
DELISTED
Biotricity, Inc. Common Stock
BTCY
$86.3K ﹤0.01%
22,549

Similar funds

State Street's Q2 2023 Portfolio in Review

As of Q2 2023, State Street held 4,852 positions worth $1.9T, up 7.4% from $1.77T the previous quarter. Its ten largest holdings account for 23% of the portfolio.

State Street's Q2 2023 filing shows 71 new, 2,184 increased, 1,624 reduced and 173 closed positions. Its largest new stake was Crane Co: 1,304,431 shares worth $116M. The largest sale was ExxonMobil, an estimated $1.34B.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

  • State Street's largest Q2 2023 buy was Crane Co: 1,304,431 shares worth $116M.
  • State Street added most to Palo Alto Networks in Q2 2023, an estimated $1.15B increase.
  • State Street's biggest Q2 2023 reduction was ExxonMobil, cutting an estimated $1.34B.
  • State Street fully exited Maxar Technologies Inc. Common Stock in Q2 2023, selling an estimated $150M.
  • State Street's ten largest holdings make up 23% of its $1.9T portfolio in Q2 2023.
  • State Street opened 71 new positions and closed 173 in Q2 2023.
  • State Street's portfolio value rose 7.4% quarter-over-quarter to $1.9T.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.